FDA-Inspected Site

Sentry Biopharma Services, Inc.

6 FDA inspections are on record for Sentry Biopharma Services, Inc. in Indianapolis, United States.

Clean· No action indicated

Indianapolis, United States · Last updated August 15, 2026

Overview

  • 6 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2025-12-17.

At a glance

Inspections

6

Form 483s

1

EIRs

2

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Dec 2025Human DrugsClean
29 Jun 2021Human DrugsClean
30 Jun 2016BiologicsClean
3 Feb 2014Human DrugsClean
6 Dec 2011Not recordedClean
22 Jul 2009Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

22 Jul 2009
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Rebecca E Dombrowski

22 Jul 2009
21 CFR 211.134(a)

Correct labels during finishing operations

Cited by Rebecca E Dombrowski

Investigators

FDA investigators tied to this site in the record.

Scott D Mcgrew1 insp.
Eboni S Funderburk1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.134(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Sentry Biopharma Services, Inc.'s 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat